While most of us, myself included, have assumed that the move of the past couple days has been the result of the US listing news, I think it may very well be the engagement of Rothschild & Co that has helped sustain and prolong the move up.  

I did some reading last night and this isn’t Canaccord or some Raymond James that’s been engaged as an advisor, and that’s not casting aspersions on those two firms…but Rothschild & Co is in an entirely different league I would venture. 

This company is headed up by a member of the French Branch of the renowned family.  Going over news pieces I don’t see them advising any other penny stock companies, but I do see them being engaged by governments and a lot of M&A type activity.

https://www.bloomberg.com/news/articles/2018-01-31/puerto-rico-hears-energy-assets-may-fetch-up-to-4-billion

If news had come out that Resverlogix had engaged even a BMO or RBC, I don’ think the market reaction would have been as robust.  While it is Resverlogix engaging Rothschild & Co I am operating on the assumption that Rothschild could have easily said, “Non merci, we have no interest in taking on the business of a little known and thinly traded development stage Canadian biotech”.   Rothschild & Co, for me upon reflection is spelling validation en masse, with a big bolded and underlined V.